Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Outlook Therapeutics Q3 EPS $(0.07) Down From $(0.03) YoY

Outlook Therapeutics (NASDAQ:OTLK) reported quarterly losses of $(0.07) per share. This is a 133.33 percent decrease over losses of $(0.03) per share from the same period last year.
byBill Haddad
August 13, 2021
1 minute read
Total
0
Shares
0
0
0
0
0
0

Outlook Therapeutics (NASDAQ:OTLK) reported quarterly losses of $(0.07) per share. This is a 133.33 percent decrease over losses of $(0.03) per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts